Exceptions to the rule in hairy cell leukaemia: Implications for molecular diagnostics and targeted therapy

Medical Oncology

Volumn 31, Issue 4, 2014, Pages

  Langabeer, Stephen E ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CLADRIBINE; MAP2K1 PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PENTOSTATIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BRAF PROTEIN, HUMAN;

CANCER DIAGNOSIS; CLONAL EVOLUTION; EXON; GENE MUTATION; GENE REARRANGEMENT; HAIRY CELL LEUKEMIA; HUMAN; LETTER; LEUKEMIA REMISSION; MOLECULAR DIAGNOSIS; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; CHROMOSOME DELETION; COHORT ANALYSIS; DNA SEQUENCE; DRUG RESISTANCE; GENETICS; MOLECULAR PATHOLOGY; MUTATION; REMISSION;

ANTINEOPLASTIC AGENTS; CHROMOSOME DELETION; COHORT STUDIES; DRUG RESISTANCE, NEOPLASM; EXONS; HUMANS; LEUKEMIA, HAIRY CELL; MUTATION; PATHOLOGY, MOLECULAR; PROTO-ONCOGENE PROTEINS B-RAF; REMISSION INDUCTION; SEQUENCE ANALYSIS, DNA;

EID: 84893934164     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0895-6     Document Type: Letter

References (7)

1. Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, Pucciarini A, Bigerna B, Pacini R, Wells VA, Sportoletti P, Pettirossi V, Mannucci R, Elliott O, Liso A, Ambrosetti A, Pulsoni A, Forconi F, Trentin L, Semenzato G, Inghirami G, Capponi M, Di Raimondo F, Patti C, Arcaini L, Musto P, Pileri S, Haferlach C, Schnittger S, Pizzolo G, Foà R, Farinelli L, Haferlach T, Pasqualucci L, Rabadan R, Falini B. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364:2305-15.
2. Xi L, Arons E, Navarro W, Calvo KR, Stetler-Stevenson M, Raffeld M, Kreitman RJ. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood. 119; 3330-2.
3. Tschernitz S, Flossbach L, Bonengel M, Roth S, Rosenwald A, Geissinger E. Alternative BRAF mutations in BRAF V600E-negative hairy cell leukaemias. Br J Haematol. Published online 16 Jan 2014. doi: 10.1111/bjh.12735.
4. Langabeer SE, O'Brien D, McElligott AM, Lavin M. BRAF V600E-negative hairy cell leukaemia. Case Rep Hematol. 2013;2013:513049.
5. Nordgren A, Corcoran M, Sääf A, Bremer A, Kluin-Nelemans HC, Schoumans J, Grandér D. Characterisation of hairy cell leukaemia by tiling resolution array-based comparative genomic hybridisation: a series of 13 cases and review of the literature. Eur J Haematol. 2010;84:17-25.
6. Waterfall JJ, Arons E, Walker RL, Pineda M, Roth L, Killian JK, Abaan OD, Davis SR, Kreitman RJ, Seltzer PS. High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias. Nat Genet. 2014;46:8-10.
7. Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J, Hamid O, Schuchter L, Cebon J, Ibrahim N, Kudchadkar R, Nurris HA 3rd, Falchook G, Algazi A, Lewis K, Long GV, Puzanov I, Lebowitz P, Singh A, Little S, Sun P, Allred A, Ouellet D, Kim KN, Patel K, Eber J. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med. 2012;367:1694-703.